Weihong Cao
No 59 Haier Road
Qingdao, 266003, China
Qingdao, 266003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer.
Journal: BMC cancer
Published: September 30, 2025
Co-administration of nobiletin and tetrahydrocurcumin enhanced the cytotoxicity to breast cancer through inhibiting CYP1A1 enzyme: from the perspective of pharmacokinetic interactions.
Journal: Discover oncology
Published: February 18, 2025
Complications and patient-reported outcomes after radiotherapy in breast cancer patients undergoing implant-based breast reconstruction: a retrospective study from a large Chinese breast disease center.
Journal: World journal of surgical oncology
Published: September 20, 2024
Erratum: [Corrigendum] Mesenchymal stem cells expressing interleukin‑18 suppress breast cancer cells in vitro.
Journal: Experimental and therapeutic medicine
Published: August 21, 2023
Hormone receptor-positive, HER2-negative, metastatic breast cancer responded well to abemaciclib and exemestane after palbociclib and fulvestrant failure: A case report and literature review.
Journal: Frontiers in oncology
Published: August 19, 2022
The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target.
Journal: Cell biology international
Published: August 10, 2022
Augmentation of antitumor function of tumor-infiltrating lymphocytes against triple-negative breast cancer by PD-1 blockade.
Journal: Cell biology international
Published: August 13, 2021
APOBEC3B expression and its prognostic potential in breast cancer.
Journal: Oncology letters
Published: July 13, 2019
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
Journal: Breast cancer (Tokyo, Japan)
Published: November 19, 2018
p53-independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cells.
Journal: Oncology letters
Published: February 28, 2018
MiR-148a suppresses invasion and induces apoptosis of breast cancer cells by regulating USP4 and BIM expression.
Journal: International journal of clinical and experimental pathology
Published: December 16, 2016
Last Updated: 09/26/2026